Cystic fibrosis gene modifier SLC26A9 modulates airway response to CFTR-directed therapeutics.
Strug LJ, Gonska T, He G, Keenan K, Ip W, Boëlle PY, Lin F, Panjwani N, Gong J, Li W, Soave D, Xiao B, Tullis E, Rabin H, Parkins MD, Price A, Zuberbuhler PC, Corvol H, Ratjen F, Sun L, Bear CE, Rommens JM.
Strug LJ, et al. Among authors: gonska t.
Hum Mol Genet. 2016 Oct 15;25(20):4590-4600. doi: 10.1093/hmg/ddw290.
Hum Mol Genet. 2016.
PMID: 28171547
Free PMC article.